CITY OF INDUSTRY, Calif. Oct. 5, 2016 – Prolacta Bioscience®, the leader in providing human milk-based neonatal nutritional products to hospital neonatal intensive care units (NICU), announced today that, through the generosity of moms who donated their excess breast milk to Prolacta-sponsored charitable milk banks, more than $1.3 million has been donated to Susan G. Komen to date in support of the fight against breast cancer.
Prolacta offers a variety of donor milk programs, including charitable and direct compensation options, for moms who wish to donate their excess breast milk to help the most fragile, critically ill babies in the NICU. For moms who choose to make a charitable contribution to one of Prolacta’s affiliated charities, such as Susan G. Komen, Prolacta donates $1 per ounce to the charity.
“The moms who donate their excess breast milk to support Susan G. Komen are supporting a cause that impacts millions of women and their families annually,” said Scott Elster, President and CEO of Prolacta Bioscience. “With their choice to donate, these moms are helping premature infants receive life-saving nutrition and care, while simultaneously helping those diagnosed with breast cancer. We are incredibly proud to support Susan G. Komen’s efforts to save lives and end breast cancer forever.”
About Prolacta Bioscience
Prolacta Bioscience, Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. The company pioneered the development of human milk-based neonatal nutritional products to meet the needs of critically ill, premature infants in the NICU. Prolacta leads the industry in the quality and safety of nutritional products made from breast milk and operates the first and only pharmaceutical-grade manufacturing facility for the processing of human breast milk. For more information please visit www.prolacta.com.